Cancerprobe Pty Ltd is a limited by shares Australian proprietary company. Located at VIC 3123 since 2014-09-13 the company is, as the updated on 2022-07-22 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2000-12-11 until 2022-06-30. Known company numbers for Cancerprobe Pty Ltd are as follows: ACN - 095341183, Australian Business Number - 83095341183. Cancerprobe Pty Ltd has been the company name since 2001-06-06. Cancerprobe Pty Ltd is one of the trading names this company has used, to be precise, the trading names list includes 2 positions that is Cancerprobe Pty Ltd since 2001-06-25, Meloma Pty Ltd since 2001-01-12 to 2001-06-25. Their official company name changed on 2001-01-12 to Meloma Pty Ltd. The company had used this name up until 2001-06-25. This company had suspended their activity from 2022-07-04 to 2022-07-04. This Australian proprietary company was previously located in VIC 3123 (from 2011-01-11 to 2014-09-13), VIC 3121 (from 2009-11-11 to 2011-01-11), VIC 3142 (from 2001-01-12 to 2009-11-11).
| Status | From | To |
|---|---|---|
| Cancelled | July 4, 2022 | current |
| Active | December 11, 2000 | July 4, 2022 |
| Name | From | To |
|---|---|---|
| Cancerprobe Pty Ltd | June 25, 2001 | current |
| Meloma Pty Ltd | January 12, 2001 | June 25, 2001 |
| Name | From | To |
|---|---|---|
| Cancerprobe Pty Ltd | June 25, 2001 | current |
| Meloma Pty Ltd | January 12, 2001 | June 25, 2001 |
| Location | From | To |
|---|---|---|
| VIC 3123 | September 13, 2014 | current |
| VIC 3123 | January 11, 2011 | September 13, 2014 |
| VIC 3121 | November 11, 2009 | January 11, 2011 |
| VIC 3142 | January 12, 2001 | November 11, 2009 |
| Status | From | To |
|---|---|---|
| Registered | December 11, 2000 | June 30, 2022 |
Advertisements
General information:
| Patent status: |
Sealed What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical. |
| Patent type: | STANDARD |
International Patent Classification:
| IPC Mark: | C07K 16/30 |
| Section code: | C - chemistrymetallurgy |
| Class code: | 7 - organic chemistry |
| Subclass code: | K - peptides (peptides containing -lactam rings c07d; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d; ergot alkaloids of the cyclic peptide type c07d0519020000; genetic engineering processes for obtaining peptides c12n0015000000) |
| Main group code: | 16 - immunoglobulins, e.g. monoclonal or polyclonal antibodies |
| Subgroup code: | 30 - from tumour cells |
IP Australia process information:
| Expiry date: | November 29, 2021 |
General information:
| Patent status: |
Lapsed Either the application has not been accepted by 21 months after the first examination report (or 12 months after the Raising the Bar Act) or some other deadline in the prosecution process has not been completed in time, for example IP Australia has issued a direction to file a request for examination and the applicant has not done so in the required period (2 months). |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | C07K 16/30 |
| Section code: | C - chemistrymetallurgy |
| Class code: | 7 - organic chemistry |
| Subclass code: | K - peptides (peptides containing -lactam rings c07d; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d; ergot alkaloids of the cyclic peptide type c07d0519020000; genetic engineering processes for obtaining peptides c12n0015000000) |
| Main group code: | 16 - immunoglobulins, e.g. monoclonal or polyclonal antibodies |
| Subgroup code: | 30 - from tumour cells |
IP Australia process information:
| Expiry date: | November 29, 2021 |
General information:
| Patent status: |
Lapsed Either the application has not been accepted by 21 months after the first examination report (or 12 months after the Raising the Bar Act) or some other deadline in the prosecution process has not been completed in time, for example IP Australia has issued a direction to file a request for examination and the applicant has not done so in the required period (2 months). |
| Patent type: | STANDARD |
International Patent Classification:
| IPC Mark: | G01N 33/574 |
| Section code: | G - physics |
| Class code: | 1 - measuring; testing |
| Subclass code: | N - investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or micro-organisms c12m, c12q) |
| Main group code: | 33 - investigating or analysing materials by specific methods not covered by groups ; g01n0001000000-g01n0031000000 |
| Subgroup code: | 574 - for cancer |
IP Australia process information:
| Expiry date: | November 29, 2021 |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.